Literature DB >> 18339626

Structural and functional characterization of disulfide isoforms of the human IgG2 subclass.

Thomas M Dillon1, Margaret Speed Ricci, Chris Vezina, Gregory C Flynn, Yaoqing Diana Liu, Douglas S Rehder, Matthew Plant, Brad Henkle, Yu Li, Songpon Deechongkit, Brian Varnum, Jette Wypych, Alain Balland, Pavel V Bondarenko.   

Abstract

In the accompanying report ( Wypych, J., Li, M., Guo, A., Zhang, Z., Martinez, T., Allen, M. J., Fodor, S., Kelner, D. N., Flynn, G. C., Liu, Y. D., Bondarenko, P. V., Ricci, M. S., Dillon, T. M., and Balland, A. (2008) J. Biol. Chem. 283, 16194-16205 ), we have identified that the human IgG2 subclass exists as an ensemble of distinct isoforms, designated IgG2-A, -B, and -A/B, which differ by the disulfide connectivity at the hinge region. In this report, we studied the structural and functional properties of the IgG2 disulfide isoforms and compared them to IgG1. Human monoclonal IgG1 and IgG2 antibodies were designed with identical antigen binding regions, specific to interleukin-1 cell surface receptor type 1. In vitro biological activity measurements showed an increased activity of the IgG1 relative to the IgG2 in blocking interleukin-1beta ligand from binding to the receptor, suggesting that some of the IgG2 isoforms had lower activity. Under reduction-oxidation conditions, the IgG2 disulfide isoforms converted to IgG2-A when 1 m guanidine was used, whereas IgG2-B was enriched in the absence of guanidine. The relative potency of the antibodies in cell-based assays was: IgG1 > IgG2-A > IgG2 >> IgG2-B. This difference correlated with an increased hydrodynamic radius of IgG2-A relative to IgG2-B, as shown by biophysical characterization. The enrichment of disulfide isoforms and activity studies were extended to additional IgG2 monoclonal antibodies with various antigen targets. All IgG2 antibodies displayed the same disulfide conversion, but only a subset showed activity differences between IgG2-A and IgG2-B. Additionally, the distribution of isoforms was influenced by the light chain type, with IgG2lambda composed mostly of IgG2-A. Based on crystal structure analysis, we propose that IgG2 disulfide exchange is caused by the close proximity of several cysteine residues at the hinge and the reactivity of tandem cysteines within the hinge. Furthermore, the IgG2 isoforms were shown to interconvert in whole blood or a "blood-like" environment, thereby suggesting that the in vivo activity of human IgG2 may be dependent on the distribution of isoforms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339626      PMCID: PMC3259628          DOI: 10.1074/jbc.M709988200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Plasma cystine concentration and redox state in aging and physical exercise.

Authors:  W Hildebrandt; R Kinscherf; K Hauer; E Holm; W Dröge
Journal:  Mech Ageing Dev       Date:  2002-05       Impact factor: 5.432

2.  Contrasting IgG structures reveal extreme asymmetry and flexibility.

Authors:  Erica Ollmann Saphire; Robyn L Stanfield; M D Max Crispin; Paul W H I Parren; Pauline M Rudd; Raymond A Dwek; Dennis R Burton; Ian A Wilson
Journal:  J Mol Biol       Date:  2002-05-24       Impact factor: 5.469

Review 3.  Therapeutic antibodies for human diseases at the dawn of the twenty-first century.

Authors:  Ole Henrik Brekke; Inger Sandlie
Journal:  Nat Rev Drug Discov       Date:  2003-01       Impact factor: 84.694

4.  Development of an analytical reversed-phase high-performance liquid chromatography-electrospray ionization mass spectrometry method for characterization of recombinant antibodies.

Authors:  Thomas M Dillon; Pavel V Bondarenko; Margaret Speed Ricci
Journal:  J Chromatogr A       Date:  2004-10-22       Impact factor: 4.759

5.  Influence of the isotype of the light chain on the properties of IgG.

Authors:  Ramon F Montaño; Sherie L Morrison
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

6.  Structural studies of immunoglobulin G.

Authors:  B Frangione; C Milstein; J R Pink
Journal:  Nature       Date:  1969-01-11       Impact factor: 49.962

Review 7.  Immunoglobulin G: functional sites.

Authors:  D R Burton
Journal:  Mol Immunol       Date:  1985-03       Impact factor: 4.407

Review 8.  Disulfide bonds as switches for protein function.

Authors:  Philip J Hogg
Journal:  Trends Biochem Sci       Date:  2003-04       Impact factor: 13.807

9.  Differential binding of histidine-rich glycoprotein (HRG) to human IgG subclasses and IgG molecules containing kappa and lambda light chains.

Authors:  N N Gorgani; C R Parish; J G Altin
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

10.  Human IgG3 can adopt the disulfide bond pattern characteristic for IgG1 without resembling it in complement mediated cell lysis.

Authors:  O H Brekke; B Bremnes; R Sandin; A Aase; T E Michaelsen; I Sandlie
Journal:  Mol Immunol       Date:  1993-11       Impact factor: 4.407

View more
  87 in total

1.  Development and validation of an antibody-dependent cell-mediated cytotoxicity-reporter gene assay.

Authors:  Bhavin S Parekh; Elaine Berger; Sharon Sibley; Suntara Cahya; Liqun Xiao; Melinda Ann LaCerte; Peter Vaillancourt; Scott Wooden; Dennis Gately
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

2.  Relative stabilities of IgG1 and IgG4 Fab domains: influence of the light-heavy interchain disulfide bond architecture.

Authors:  James T Heads; Ralph Adams; Lena E D'Hooghe; Matt J T Page; David P Humphreys; Andrew G Popplewell; Alastair D Lawson; Alistair J Henry
Journal:  Protein Sci       Date:  2012-08-09       Impact factor: 6.725

Review 3.  Strategies and challenges for the next generation of therapeutic antibodies.

Authors:  Alain Beck; Thierry Wurch; Christian Bailly; Nathalie Corvaia
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

Review 4.  Stability of IgG isotypes in serum.

Authors:  Ivan R Correia
Journal:  MAbs       Date:  2010-05-16       Impact factor: 5.857

5.  The use of native cation-exchange chromatography to study aggregation and phase separation of monoclonal antibodies.

Authors:  Shuang Chen; Hollis Lau; Yan Brodsky; Gerd R Kleemann; Ramil F Latypov
Journal:  Protein Sci       Date:  2010-06       Impact factor: 6.725

6.  Computational tool for the early screening of monoclonal antibodies for their viscosities.

Authors:  Neeraj J Agrawal; Bernhard Helk; Sandeep Kumar; Neil Mody; Hasige A Sathish; Hardeep S Samra; Patrick M Buck; Li Li; Bernhardt L Trout
Journal:  MAbs       Date:  2015-09-23       Impact factor: 5.857

7.  Characterization and comparison of disulfide linkages and scrambling patterns in therapeutic monoclonal antibodies: using LC-MS with electron transfer dissociation.

Authors:  Yi Wang; Qiaozhen Lu; Shiaw-Lin Wu; Barry L Karger; William S Hancock
Journal:  Anal Chem       Date:  2011-03-23       Impact factor: 6.986

8.  Conformational isomers of denatured and unfolded proteins: methods of production and applications.

Authors:  Jui-Yoa Chang
Journal:  Protein J       Date:  2009-01       Impact factor: 2.371

9.  Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell-Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification.

Authors:  M Christian Tjiam; James P A Taylor; Mazmah A Morshidi; Lucy Sariputra; Sally Burrows; Jeffrey N Martin; Steven G Deeks; Dino B A Tan; Silvia Lee; Sonia Fernandez; Martyn A French
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

10.  Characterization of Disulfide Linkages in Proteins by 193 nm Ultraviolet Photodissociation (UVPD) Mass Spectrometry.

Authors:  M Montana Quick; Christopher M Crittenden; Jake A Rosenberg; Jennifer S Brodbelt
Journal:  Anal Chem       Date:  2018-06-28       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.